cilostazol - 60505-2521-8 - (cilostazol)

Alphabetical Index


Drug Information of cilostazol

Product NDC: 60505-2521
Proprietary Name: cilostazol
Non Proprietary Name: cilostazol
Active Ingredient(s): 50    mg/1 & nbsp;   cilostazol
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of cilostazol

Product NDC: 60505-2521
Labeler Name: Apotex Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA077030
Marketing Category: ANDA
Start Marketing Date: 20111018

Package Information of cilostazol

Package NDC: 60505-2521-8
Package Description: 1000 TABLET in 1 BOTTLE (60505-2521-8)

NDC Information of cilostazol

NDC Code 60505-2521-8
Proprietary Name cilostazol
Package Description 1000 TABLET in 1 BOTTLE (60505-2521-8)
Product NDC 60505-2521
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name cilostazol
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20111018
Marketing Category Name ANDA
Labeler Name Apotex Corp.
Substance Name CILOSTAZOL
Strength Number 50
Strength Unit mg/1
Pharmaceutical Classes Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA]

Complete Information of cilostazol


General Information